Pub Date : 2020-10-02DOI: 10.19080/ARGH.2020.16.555926
S. Salah
Introduction: Gadarif is an endemic area of medical disorders causing splenomegaly in patients who are also subjected to abdominal trauma. Despite the lack of resources, which make adherence to the international guidelines of NOMSI somehow difficult, we apply it based on clinical evaluation, laboratory tests and ultrasound. Objectives: To study the outcome of NOMSI based on hemodynamic stability, ultrasound findings and follow-up. Methods: A prospective analytic hospital based study conducted in Gadarif, Eastern Sudan from 2015 to 2019, including patients who were having splenic injury with no clear indication for immediate surgery. Results: A total of 30 patients were included, of them 29 (96.7%) were male. Their age ranges between 7-65 years with the mean of 29.8. Twenty patients (66.7%) presented within 24 hours from trauma, while the rest presented later. Three patients (10%) had no history of abdominal trauma, one is an epileptic and the other 2 had concomitant severe malaria. Hemodynamic instability at presentation was found in 14 patients (46.7 %). Left hypochondrial pain was the predominant symptom in 20 patients (66.7 %) and two thirds of patients had tender LHQ. More than half (53.3%) had splenic hematoma/laceration on initial ultrasound. We encountered 5 (16.6%) patients with pathological spleens of Malaria or Visceral Leishmaniasis (Kala-azar). Four patients (13.3%), of those who had increased spleen size on initial US scan, were hemodynamically unstable and required emergency splenectomy resulting in a success rate of NOMSI in 86.7%. Conclusion: NOMSI based on clinical judgment and ultrasound examination in limited resources setup, is feasible and applicable with comparable success rates. Further studies are needed to evaluate NOMSI in endemic areas with pathological spleen.
{"title":"Non-Operative Management of Splenic Injuries (NOMSI) in a Limited Resources Setup","authors":"S. Salah","doi":"10.19080/ARGH.2020.16.555926","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555926","url":null,"abstract":"Introduction: Gadarif is an endemic area of medical disorders causing splenomegaly in patients who are also subjected to abdominal trauma. Despite the lack of resources, which make adherence to the international guidelines of NOMSI somehow difficult, we apply it based on clinical evaluation, laboratory tests and ultrasound. Objectives: To study the outcome of NOMSI based on hemodynamic stability, ultrasound findings and follow-up. Methods: A prospective analytic hospital based study conducted in Gadarif, Eastern Sudan from 2015 to 2019, including patients who were having splenic injury with no clear indication for immediate surgery. Results: A total of 30 patients were included, of them 29 (96.7%) were male. Their age ranges between 7-65 years with the mean of 29.8. Twenty patients (66.7%) presented within 24 hours from trauma, while the rest presented later. Three patients (10%) had no history of abdominal trauma, one is an epileptic and the other 2 had concomitant severe malaria. Hemodynamic instability at presentation was found in 14 patients (46.7 %). Left hypochondrial pain was the predominant symptom in 20 patients (66.7 %) and two thirds of patients had tender LHQ. More than half (53.3%) had splenic hematoma/laceration on initial ultrasound. We encountered 5 (16.6%) patients with pathological spleens of Malaria or Visceral Leishmaniasis (Kala-azar). Four patients (13.3%), of those who had increased spleen size on initial US scan, were hemodynamically unstable and required emergency splenectomy resulting in a success rate of NOMSI in 86.7%. Conclusion: NOMSI based on clinical judgment and ultrasound examination in limited resources setup, is feasible and applicable with comparable success rates. Further studies are needed to evaluate NOMSI in endemic areas with pathological spleen.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42197793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-15DOI: 10.19080/ARGH.2020.15.555924
Byshetty Rajendar
Midline laparotomies constitute a majority of intra-abdominal elective and emergency surgical procedures. Midline laparotomy results in postoperative effects on the patient, which include pain with subsequent immobilisation along with decreased pulmonary function and abdominal muscle laxity. Pain is the most incapacitating of all those mentioned, due to its effect on the physical condition and psyche of the patient. Pain after laparotomy is a frequent complication and the prevalence of pain after midline laparotomy is reported as high as 80%. Pain if inadequately treated will cause complications, which can range from short term complications which include hyperglycaemia, increased surgical site infection to long term complications like decreased quality of life and development of chronic pain syndrome [1]. Pain management includes various methods like use of drugs and several newer analgesic/ anaesthetic techniques. One of the simplest and cheapest mechanisms of the many studied and researched is the use of abdominal binders.
{"title":"Role of Incision Support Using Elastic Abdominal Binders in Reducing Postoperative Pain after Midline Laparotomy: A Randomized Controlled Trial","authors":"Byshetty Rajendar","doi":"10.19080/ARGH.2020.15.555924","DOIUrl":"https://doi.org/10.19080/ARGH.2020.15.555924","url":null,"abstract":"Midline laparotomies constitute a majority of intra-abdominal elective and emergency surgical procedures. Midline laparotomy results in postoperative effects on the patient, which include pain with subsequent immobilisation along with decreased pulmonary function and abdominal muscle laxity. Pain is the most incapacitating of all those mentioned, due to its effect on the physical condition and psyche of the patient. Pain after laparotomy is a frequent complication and the prevalence of pain after midline laparotomy is reported as high as 80%. Pain if inadequately treated will cause complications, which can range from short term complications which include hyperglycaemia, increased surgical site infection to long term complications like decreased quality of life and development of chronic pain syndrome [1]. Pain management includes various methods like use of drugs and several newer analgesic/ anaesthetic techniques. One of the simplest and cheapest mechanisms of the many studied and researched is the use of abdominal binders.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43288676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-10DOI: 10.19080/ARGH.2020.15.555923
G. Teuber
Aims: Concerning the durability of HBsAg loss during or after antiviral treatment only a few studies with conflicting results are available indicating a rate of reactivation with reocurrence of HBsAg and/or HBV-DNA in 4.2% 16.4% in predominantly Asian patients. However, there are no larger European studies available concerning the durability of HBsAg loss during or after antiviral treatment and the impact on further clinical outcome. Patients and Methods: In this retrospective German multicentre study, 143 patients with chronic hepatitis B (mean age: 43 ± 13.8 years, 93 males, 50 females) who lost HBsAg during or after antiviral treatment were included. Antiviral treatment with peginterferon-alpha2a (PegIFNalpha2a) and/or nucleus(t)ides were administered between April 2008 and July 2014. Before antiviral treatment, 17 patients had established liver cirrhosis. Primary endpoint was reactivation with reoccurrence of HBsAg Further endpoints were clinical progressive liver disease, liver transplantation and death. Result: During the follow-up period (mean: 3.0 ± 2.1 years) a reoccurrence of HBsAg was observed in only 3/143 patients (2.1%), and in none with previous seroconversion to Anti-HBs. The HBV reactivation in these patients was not associated with detectable HBV-DNA levels, 2/3 patients had baseline cirrhosis and 1/2 subsequently died due to recurrent multifocal hepatocellular carcinoma. Among the 140 patients with persisting HBsAg loss, two initially cirrhotic patients died, and one received liver transplantation all due to hepatocellular carcinoma. Conclusion: In a predominantly Caucasian patient population HBsAg loss during and/or after antiviral treatment seems to be durable with low rates of reactivation. Cirrhotic patients, however, have a high risk developing hepatocellular carcinoma even after HBsAg loss. Continous surveillance in these patients seems to be mandatory.
{"title":"Durability of Hbsag Loss During or After Antiviral Treatment and Impact on Clinical Outcome","authors":"G. Teuber","doi":"10.19080/ARGH.2020.15.555923","DOIUrl":"https://doi.org/10.19080/ARGH.2020.15.555923","url":null,"abstract":"Aims: Concerning the durability of HBsAg loss during or after antiviral treatment only a few studies with conflicting results are available indicating a rate of reactivation with reocurrence of HBsAg and/or HBV-DNA in 4.2% 16.4% in predominantly Asian patients. However, there are no larger European studies available concerning the durability of HBsAg loss during or after antiviral treatment and the impact on further clinical outcome. Patients and Methods: In this retrospective German multicentre study, 143 patients with chronic hepatitis B (mean age: 43 ± 13.8 years, 93 males, 50 females) who lost HBsAg during or after antiviral treatment were included. Antiviral treatment with peginterferon-alpha2a (PegIFNalpha2a) and/or nucleus(t)ides were administered between April 2008 and July 2014. Before antiviral treatment, 17 patients had established liver cirrhosis. Primary endpoint was reactivation with reoccurrence of HBsAg Further endpoints were clinical progressive liver disease, liver transplantation and death. Result: During the follow-up period (mean: 3.0 ± 2.1 years) a reoccurrence of HBsAg was observed in only 3/143 patients (2.1%), and in none with previous seroconversion to Anti-HBs. The HBV reactivation in these patients was not associated with detectable HBV-DNA levels, 2/3 patients had baseline cirrhosis and 1/2 subsequently died due to recurrent multifocal hepatocellular carcinoma. Among the 140 patients with persisting HBsAg loss, two initially cirrhotic patients died, and one received liver transplantation all due to hepatocellular carcinoma. Conclusion: In a predominantly Caucasian patient population HBsAg loss during and/or after antiviral treatment seems to be durable with low rates of reactivation. Cirrhotic patients, however, have a high risk developing hepatocellular carcinoma even after HBsAg loss. Continous surveillance in these patients seems to be mandatory.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43142472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-01DOI: 10.19080/ARGH.2020.15.555922
G. SalamaA, M. A. Tawfik
Background and study aim: The bleeding from gastric varices are more severe, requiring more blood transfusions, and has a higher mortality rate than esophageal variceal bleeding, there is little data on primary prophylaxis of GV bleeding, we compared the efficacy of cyanoacrylate injection and beta-blockers in primary prophylaxis of gastric variceal bleeding. Methods: Cirrhotics with gastroesophageal varices type 2 with eradicated esophageal varices or large isolated gastric varix type 1, who had never bled from gastric varix, were randomized to cyanoacrylate injection (Group I, n = 30), beta-blockers (Group II, n = 30) or no treatment (Group III, n = 30). Primary endpoints were bleeding from gastric varix or death. Results: bleeding from gastric varices over 6 months follow up was 6.67% in Group I, 20% in Group II, 36.67% in Group III (p = 0.017). GV obliterated or decreased in size 42.86% and 57.14% of group I respectively. No patients neither in group II nor in group III had an obliteration or decrease in GV size. (p < 0.001). Conclusion: Primary prophylaxis in patients with gastric varices is recommended to reduce the risk of first bleeding. Cyanoacrylate injection is more effective than beta-blocker therapy in preventing first gastric variceal bleeding.
{"title":"Primary Prophylaxis of Gastric Variceal Bleeding Comparing Cyanoacrylate Injection and Beta-Blockers in Patients with Liver Cirrhosis: A Randomized Controlled Trial","authors":"G. SalamaA, M. A. Tawfik","doi":"10.19080/ARGH.2020.15.555922","DOIUrl":"https://doi.org/10.19080/ARGH.2020.15.555922","url":null,"abstract":"Background and study aim: The bleeding from gastric varices are more severe, requiring more blood transfusions, and has a higher mortality rate than esophageal variceal bleeding, there is little data on primary prophylaxis of GV bleeding, we compared the efficacy of cyanoacrylate injection and beta-blockers in primary prophylaxis of gastric variceal bleeding. Methods: Cirrhotics with gastroesophageal varices type 2 with eradicated esophageal varices or large isolated gastric varix type 1, who had never bled from gastric varix, were randomized to cyanoacrylate injection (Group I, n = 30), beta-blockers (Group II, n = 30) or no treatment (Group III, n = 30). Primary endpoints were bleeding from gastric varix or death. Results: bleeding from gastric varices over 6 months follow up was 6.67% in Group I, 20% in Group II, 36.67% in Group III (p = 0.017). GV obliterated or decreased in size 42.86% and 57.14% of group I respectively. No patients neither in group II nor in group III had an obliteration or decrease in GV size. (p < 0.001). Conclusion: Primary prophylaxis in patients with gastric varices is recommended to reduce the risk of first bleeding. Cyanoacrylate injection is more effective than beta-blocker therapy in preventing first gastric variceal bleeding.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42708992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-10DOI: 10.19080/argh.2020.15.555914
Ibrahim Ahmad H. El Bacha, M. Elias, I. Silva, A. Martins, E. Parise
Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Traditionally, elevated serum ferritin is related to the presence of iron accumulation in the body, especially in the liver. However, in chronic hepatitis C several other factors have been alternatively associated with hyperferritinemia, such as liver enzymes, metabolic factors, hepatic steatosis and liver fibrosis. This study aimed to evaluated the exact contribution of these variables to ferritin serum levels in chronic hepatitis.
{"title":"Hyperferritinemia Has Multifactorial Etiology in Naive Patients with Chronic Hepatitis C","authors":"Ibrahim Ahmad H. El Bacha, M. Elias, I. Silva, A. Martins, E. Parise","doi":"10.19080/argh.2020.15.555914","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555914","url":null,"abstract":"Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Traditionally, elevated serum ferritin is related to the presence of iron accumulation in the body, especially in the liver. However, in chronic hepatitis C several other factors have been alternatively associated with hyperferritinemia, such as liver enzymes, metabolic factors, hepatic steatosis and liver fibrosis. This study aimed to evaluated the exact contribution of these variables to ferritin serum levels in chronic hepatitis.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44256338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-07DOI: 10.19080/argh.2020.15.555913
Febyan, Ruswhandi
Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Cholelithiasis is one of the most prevalent diseases in gastroenterology. There are many factors in cholelithiasis, such as genetic, lack of physical activity, obesity, dietary, age, and other comorbidities. Commonly, cholelithiasis occurs asymptomatically; however, Murphy’s sign is one of the most frequent pathognomonic findings in abdominal examination. Ultrasonography is known as the gold standard imaging examination in diagnosing cholelithiasis. The management of cholelithiasis can be divided into two categories, such as medical treatment and surgical treatment, which depends on the patient’s condition.
{"title":"Cholelithiasis: A Brief Review on Diagnostic Approach and Management in Clinical Practice","authors":"Febyan, Ruswhandi","doi":"10.19080/argh.2020.15.555913","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555913","url":null,"abstract":"Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Cholelithiasis is one of the most prevalent diseases in gastroenterology. There are many factors in cholelithiasis, such as genetic, lack of physical activity, obesity, dietary, age, and other comorbidities. Commonly, cholelithiasis occurs asymptomatically; however, Murphy’s sign is one of the most frequent pathognomonic findings in abdominal examination. Ultrasonography is known as the gold standard imaging examination in diagnosing cholelithiasis. The management of cholelithiasis can be divided into two categories, such as medical treatment and surgical treatment, which depends on the patient’s condition.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47636142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-02DOI: 10.19080/argh.2020.15.555912
Guney Merve
Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Current and historical prevalence and mortality data from published sources and international databases show that liver disease is a very important and growing public health problem in European countries [1]. In some parts of Europe, it is estimated that there are more than 1100/10000 cirrhosis and other chronic liver patients.
{"title":"Nutritional Status of the Patients with Chronic Liver Disease are More often Overlooked During Clinical Observations","authors":"Guney Merve","doi":"10.19080/argh.2020.15.555912","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555912","url":null,"abstract":"Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Current and historical prevalence and mortality data from published sources and international databases show that liver disease is a very important and growing public health problem in European countries [1]. In some parts of Europe, it is estimated that there are more than 1100/10000 cirrhosis and other chronic liver patients.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47189664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-12DOI: 10.19080/argh.2020.15.555911
Z. P. Sharma, Ravi C. Sharma, D. Sharma
Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Esophageal submucosal haemotoma is one of the rare disorders of upper gastro intestinal tract and it is considered to be a form of injury to esophagus. There are two types of esophageal injuries: mechanical and chemical injuries. Mechanical injury is subdivided into traumatic and spontaneous ones. Here we present a case of submucosal haemotoma associated with opium intake.
{"title":"Unusual Submucosal Haemotoma in Esophagus on Upper G.I. Endoscopy","authors":"Z. P. Sharma, Ravi C. Sharma, D. Sharma","doi":"10.19080/argh.2020.15.555911","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555911","url":null,"abstract":"Journal of clinical gastroenterology is part of the Juniper publishers which is devoted to publish subject-specific articles focused on the needs of individual research communities across all areas of biology and medicine. Esophageal submucosal haemotoma is one of the rare disorders of upper gastro intestinal tract and it is considered to be a form of injury to esophagus. There are two types of esophageal injuries: mechanical and chemical injuries. Mechanical injury is subdivided into traumatic and spontaneous ones. Here we present a case of submucosal haemotoma associated with opium intake.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47022736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-08DOI: 10.19080/argh.2020.15.555909
Byshetty Rajendar
{"title":"Reversed Intestinal Rotation with Annular Pancreas Presented as Acute Necrotizing Pancreatitis- A Case report","authors":"Byshetty Rajendar","doi":"10.19080/argh.2020.15.555909","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555909","url":null,"abstract":"","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46861848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-05DOI: 10.19080/argh.2020.15.555908
A. Strombom
{"title":"Ulcerative Colitis – Prevention and Treatment with a Plant-Based Diet","authors":"A. Strombom","doi":"10.19080/argh.2020.15.555908","DOIUrl":"https://doi.org/10.19080/argh.2020.15.555908","url":null,"abstract":"","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43439935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：